Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies

Biliary tract cancers (BTCs) are rare and aggressive malignancies with an increasing incidence and poor prognosis. The standard systemic treatment for BTCs has evolved to include immune checkpoint inhibitors associated with gemcitabine–cisplatin as first-line therapies. However, survival rates remai...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mar Ros-Buxó, Ezequiel Mauro, Tamara Sauri, Gemma Iserte, Carla Fuster-Anglada, Alba Díaz, Laura Sererols-Viñas, Silvia Affo, Alejandro Forner
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-06-01
coleção:	Current Oncology
Assuntos:	BTC cholangiocarcinoma molecular profile ESCAT FGFR2 IDH1
Acesso em linha:	https://www.mdpi.com/1718-7729/31/7/266
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!